Recent Advances In Hematology 2022 ADCs, Bispecific Antibodies, CAR-T Cells…
Several innovative therapies are now available for hematology disorders, including six CAR-T therapies that have received FDA approval. There are also three of the five bispecific antibodies currently approved globally for the treatment of hematology disorders, including Lunsumio, which received EU approval in June 2022. In this article, we will share with you the latest advances in innovative hematology therapies.
-
Follow
-
1
-
Embed
-
Share
-
Upload
